|Bid||281.66 x 800|
|Ask||291.55 x 1000|
|Day's Range||284.00 - 296.00|
|52 Week Range||195.88 - 309.60|
|Beta (5Y Monthly)||1.01|
|PE Ratio (TTM)||10.26|
|Earnings Date||Feb 09, 2022 - Feb 14, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Mar 29, 1994|
|1y Target Est||336.14|
Subscribe to Yahoo Finance Plus to view Fair Value for LHLearn more
Investors are optimistic about Abbott (ABT) owing to strong third-quarter results and bullish 2021 outlook.
Strength in Bio Rad's (BIO) key product lines across major geographic regions buoys optimism.
Investors are optimistic about Bio-Rad (BIO) on strength in its key product lines and raised 2021 guidance.